Additional file 3: of Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?

Table S3. Effect and Predictive Value of “Tumor Size Changes” and “RECIST-based Response Status” on OS in Melanoma Patients (Ipilimumab-Naive Melanoma (KEYNOTE -006)). (DOCX 37 kb)